Litcius/Paper detail

Integrative clinical and molecular characterization of translocation renal cell carcinoma

Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, Nebiyou Y. Metaferia, Jiao Li, Shatha AbuHammad, Stephen Tang, Thomas Denize, Emma R. Garner, Xīn Gào, David A. Braun, Laure Hirsch, John A. Steinharter, Gabrielle Bouchard, Emily Walton, Destiny West, Chris Labaki, Shaan Dudani, Chun-Loo Gan, Vidyalakshmi Sethunath, Filipe L.F. Carvalho, Alma Imamović, Cora A. Ricker, Natalie I. Vokes, Jackson Nyman, Jacob E. Berchuck, Jihye Park, Michelle S. Hirsch, Rizwan Haq, Gwo‐Shu Mary Lee, Bradley A. McGregor, Steven L. Chang, Adam S. Feldman, Catherine J. Wu, David F. McDermott, Daniel Yick Chin Heng, Sabina Signoretti, Eliezer M. Van Allen, Toni K. Choueiri, Srinivas R. Viswanathan

2022Cell Reports116 citationsDOIOpen Access PDF

Abstract

T cells, though the T cells harbor an exhaustion immunophenotype distinct from that of clear cell RCC. Our findings comprehensively define the clinical and molecular features of tRCC and may inspire new therapeutic hypotheses.

Topics & Concepts

Chromosomal translocationRenal cell carcinomaBiologyCancer researchKidney cancerSomatic cellCD8ChromosomeImmune checkpointGeneImmune systemImmunologyPathologyMedicineImmunotherapyGeneticsRenal cell carcinoma treatmentCancer Genomics and DiagnosticsFerroptosis and cancer prognosis
Integrative clinical and molecular characterization of translocation renal cell carcinoma | Litcius